Skin barrier dysfunctions play a primary role in AD pathogenesis. There are several common barrier defects of which many have a genetic origin. In general, genetics and environmental factors contribute most to stratum corneum defects. Prof. John Su and Dr Katherine Armour (Monash University; Dermatology Institute of Victoria, Australia) shared their vision on ceramides in skin barrier improvement [1].
Ceramides are the main component of the stratum corneum of the epidermis. Along with cholesterol and saturated fatty acids, they create a water-impermeable layer that prevents the entry of microorganisms. Thus, ceramides are a natural moisturising factor that helps in barrier formation, function, and repair. Natural ceramides in the skin fluctuate with seasonal changes and reduce with ageing, AD, and psoriasis. For example, dry skin has fewer and shorter chain ceramides, specifically lacking the ceramide EOP. Eczema-prone skin is also associated with a deficient level of ceramides.
Research has shown that daily moisturising increases the time until the next AD flare-up. Dermatologists generally recommend cleaning the skin thoroughly but gently and carefully. There is no standard frequency or duration for bathing, but low pH, hypoallergenic, fragrance-free cleansers should be recommended. After bathing, it is important to pat the skin gently and to apply a moisturiser immediately to increase hydration. Ceramides EOP, NP, and AP are the most worthwhile ingredients to look for in skincare products.
Other additives that can be added to skincare to improve barrier function include zinc sulphate and copper sulphate (antibacterial action), niacinamide (barrier support, anti-inflammatory), and colloidal oatmeal (anti-pruritic, anti-inflammatory, antioxidant).
In conclusion, ceramides are lipids that are found naturally in high concentrations in the stratum corneum. They can be naturally reduced due to several factors, but adding them through ceramide-rich skincare supports skin barrier repair and function.
- Su J, et al. Atopic skin: A close-up upon skin barrier dysfunction. BIODERMA (NAOS) Symposium, ICD 2021, 10–13 November.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« 10% thioglycolic acid gel peels: a safe and efficient option for pigmented purpuric dermatosis Next Article
Registry of vitiligo patients aims to break the stigma »
« 10% thioglycolic acid gel peels: a safe and efficient option for pigmented purpuric dermatosis Next Article
Registry of vitiligo patients aims to break the stigma »
Table of Contents: ICD 2021
Featured articles
Autologous serum therapy benefits chronic spontaneous urticaria
ICD Round-Up Articles
An unusual case of E. coli cellulitis in an immunocompetent patient
Autologous serum therapy benefits chronic spontaneous urticaria
Comparing routes of administration of methotrexate in psoriasis patients
Expanding the toolbox: what is new in melanoma detection?
Equity in dermatology: Skin Care For All
Challenges in diagnosis and treatment of leprosy in Brazil
A PASSION to provide dermatological care in LMICs
Paediatric dermatology in Tunisia: common diagnoses
Registry of vitiligo patients aims to break the stigma
10% thioglycolic acid gel peels: a safe and efficient option for pigmented purpuric dermatosis
Benefits of microneedling with platelet-rich plasma for acne scars
Related Articles
December 2, 2021
Age at disease onset: a key factor in understanding psoriasis
December 2, 2021
Registry of vitiligo patients aims to break the stigma
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com